Shell Companies
Compare Stocks
5 / 10Stock Comparison
ALCY vs APO vs KKR vs CG vs ARES
Revenue, margins, valuation, and 5-year total return — side by side.
Asset Management - Global
Asset Management
Asset Management
Asset Management
ALCY vs APO vs KKR vs CG vs ARES — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Shell Companies | Asset Management - Global | Asset Management | Asset Management | Asset Management |
| Market Cap | $119M | $76.79B | $91.40B | $18.29B | $41.46B |
| Revenue (TTM) | $0.00 | $30.30B | $19.26B | $4.90B | $6.47B |
| Net Income (TTM) | $3M | $2.15B | $2.37B | $547M | $527M |
| Gross Margin | — | 88.5% | 41.8% | 65.9% | 74.8% |
| Operating Margin | — | 34.4% | 2.4% | 26.2% | 27.2% |
| Forward P/E | 27.8x | 14.9x | 16.9x | 12.3x | 20.9x |
| Total Debt | $530K | $13.36B | $54.77B | $13.89B | $14.91B |
| Cash & Equiv. | $181K | $19.24B | $6M | $3.21B | $1.50B |
ALCY vs APO vs KKR vs CG vs ARES — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jul 23 | May 26 | Return |
|---|---|---|---|
| Alchemy Investments… (ALCY) | 100 | 117.1 | +17.1% |
| Apollo Global Manag… (APO) | 100 | 163.0 | +63.0% |
| KKR & Co. Inc. (KKR) | 100 | 172.7 | +72.7% |
| The Carlyle Group I… (CG) | 100 | 142.0 | +42.0% |
| Ares Management Cor… (ARES) | 100 | 127.2 | +27.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: ALCY vs APO vs KKR vs CG vs ARES
Each card shows where this stock fits in a portfolio — not just who wins on paper.
ALCY ranks third and is worth considering specifically for sleep-well-at-night.
- Lower volatility, beta 0.02, Low D/E 10.4%, current ratio 0.13x
- Beta 0.02 vs CG's 1.85, lower leverage
APO is the clearest fit if your priority is valuation efficiency.
- PEG 0.20 vs ARES's 1.19
- Lower P/E (14.9x vs 20.9x), PEG 0.20 vs 1.19
KKR has the current edge in this matchup, primarily because of its strength in quality and efficiency.
- Efficiency ratio 0.4% vs APO's 0.5% (lower = leaner)
- Efficiency ratio 0.4% vs APO's 0.5%
CG is the clearest fit if your priority is bank quality.
- NIM 7.1% vs KKR's 0.0%
- +26.1% vs ARES's -21.0%
ARES is the #2 pick in this set and the best alternative if income & stability and growth exposure is your priority.
- Dividend streak 7 yrs, beta 1.62, yield 6.4%
- Rev growth 66.6%, EPS growth -5.3%
- 9.5% 10Y total return vs APO's 7.9%
- Beta 1.62, yield 6.4%, current ratio 2.24x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 66.6% NII/revenue growth vs KKR's -11.0% | |
| Value | Lower P/E (14.9x vs 20.9x), PEG 0.20 vs 1.19 | |
| Quality / Margins | Efficiency ratio 0.4% vs APO's 0.5% (lower = leaner) | |
| Stability / Safety | Beta 0.02 vs CG's 1.85, lower leverage | |
| Dividends | 6.4% yield, 7-year raise streak, vs APO's 1.6%, (1 stock pays no dividend) | |
| Momentum (1Y) | +26.1% vs ARES's -21.0% | |
| Efficiency (ROA) | Efficiency ratio 0.4% vs APO's 0.5% |
ALCY vs APO vs KKR vs CG vs ARES — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
ALCY vs APO vs KKR vs CG vs ARES — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
APO leads in 2 of 6 categories
ARES leads 1 • ALCY leads 0 • KKR leads 0 • CG leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
Evenly matched — APO and KKR each lead in 2 of 5 comparable metrics.
Income & Cash Flow (Last 12 Months)
APO and ALCY operate at a comparable scale, with $30.3B and $0 in trailing revenue. CG is the more profitable business, keeping 16.5% of every revenue dollar as net income compared to ARES's 8.2%.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $0 | $30.3B | $19.3B | $4.9B | $6.5B |
| EBITDAEarnings before interest/tax | -$1M | $10.0B | $9.0B | $1.0B | $1.8B |
| Net IncomeAfter-tax profit | $3M | $2.1B | $2.4B | $547M | $527M |
| Free Cash FlowCash after capex | -$907,212 | $4.4B | $7.5B | -$1.4B | $1.5B |
| Gross MarginGross profit ÷ Revenue | — | +88.5% | +41.8% | +65.9% | +74.8% |
| Operating MarginEBIT ÷ Revenue | — | +34.4% | +2.4% | +26.2% | +27.2% |
| Net MarginNet income ÷ Revenue | — | +14.8% | +12.3% | +16.5% | +8.2% |
| FCF MarginFCF ÷ Revenue | — | +24.6% | +49.4% | +27.8% | +23.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | — | — | — | — | — |
| EPS Growth (YoY)Latest quarter vs prior year | -170.4% | -5.8% | -1.7% | -2.1% | -80.9% |
Valuation Metrics
APO leads this category, winning 4 of 7 comparable metrics.
Valuation Metrics
At 18.3x trailing earnings, APO trades at a 72% valuation discount to ARES's 64.4x P/E. Adjusting for growth (PEG ratio), APO offers better value at 0.24x vs ARES's 3.65x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $119M | $76.8B | $91.4B | $18.3B | $41.5B |
| Enterprise ValueMkt cap + debt − cash | $119M | $70.9B | $146.2B | $29.0B | $54.9B |
| Trailing P/EPrice ÷ TTM EPS | 27.77x | 18.35x | 43.81x | 23.22x | 64.41x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 14.94x | 16.89x | 12.32x | 20.92x |
| PEG RatioP/E ÷ EPS growth rate | — | 0.24x | — | 1.32x | 3.65x |
| EV / EBITDAEnterprise value multiple | — | 6.19x | 20.51x | 21.67x | 27.39x |
| Price / SalesMarket cap ÷ Revenue | — | 2.53x | 4.75x | 3.73x | 6.41x |
| Price / BookPrice ÷ Book value/share | 23.34x | 1.90x | 1.20x | 2.66x | 3.15x |
| Price / FCFMarket cap ÷ FCF | — | 10.30x | 9.60x | 13.41x | 26.85x |
Profitability & Efficiency
Evenly matched — ALCY and APO each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
ALCY delivers a 52.9% return on equity — every $100 of shareholder capital generates $53 in annual profit, vs $3 for KKR. ALCY carries lower financial leverage with a 0.10x debt-to-equity ratio, signaling a more conservative balance sheet compared to CG's 1.97x. On the Piotroski fundamental quality scale (0–9), ARES scores 8/9 vs APO's 3/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | +52.9% | +5.5% | +3.2% | +7.8% | +6.2% |
| ROA (TTM)Return on assets | +20.3% | +0.5% | +0.6% | +2.0% | +1.9% |
| ROICReturn on invested capital | -1.5% | +16.0% | +0.3% | +5.2% | +6.1% |
| ROCEReturn on capital employed | -1.8% | +8.8% | +0.1% | +5.0% | +7.3% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 3 | 6 | 4 | 8 |
| Debt / EquityFinancial leverage | 0.10x | 0.31x | 0.67x | 1.97x | 1.71x |
| Net DebtTotal debt minus cash | $348,826 | -$5.9B | $54.8B | $10.7B | $13.4B |
| Cash & Equiv.Liquid assets | $181,174 | $19.2B | $6M | $3.2B | $1.5B |
| Total DebtShort + long-term debt | $530,000 | $13.4B | $54.8B | $13.9B | $14.9B |
| Interest CoverageEBIT ÷ Interest expense | -10.99x | 26.54x | 3.29x | 1.84x | 2.68x |
Total Returns (Dividends Reinvested)
APO leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARES five years ago would be worth $26,779 today (with dividends reinvested), compared to $11,660 for ALCY. Over the past 12 months, CG leads with a +26.1% total return vs ARES's -21.0%. The 3-year compound annual growth rate (CAGR) favors APO at 30.9% vs ALCY's 5.3% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -17.4% | -8.8% | -20.3% | -16.2% | -23.3% |
| 1-Year ReturnPast 12 months | +1.8% | +1.5% | -13.0% | +26.1% | -21.0% |
| 3-Year ReturnCumulative with dividends | +16.6% | +124.5% | +112.2% | +109.9% | +68.5% |
| 5-Year ReturnCumulative with dividends | +16.6% | +146.9% | +85.4% | +28.4% | +167.8% |
| 10-Year ReturnCumulative with dividends | +16.6% | +790.9% | +732.3% | +291.0% | +951.4% |
| CAGR (3Y)Annualised 3-year return | +5.3% | +30.9% | +28.5% | +28.0% | +19.0% |
Risk & Volatility
Evenly matched — ALCY and APO each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALCY is the less volatile stock with a 0.02 beta — it tends to amplify market swings less than CG's 1.85 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. APO currently trades 84.7% from its 52-week high vs ARES's 64.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.02x | 1.44x | 1.66x | 1.85x | 1.62x |
| 52-Week HighHighest price in past year | $15.90 | $157.28 | $153.87 | $69.85 | $195.26 |
| 52-Week LowLowest price in past year | $10.25 | $99.56 | $82.67 | $40.73 | $95.80 |
| % of 52W HighCurrent price vs 52-week peak | +75.1% | +84.7% | +66.6% | +72.5% | +64.7% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 60.9 | 51.4 | 47.6 | 61.9 |
| Avg Volume (50D)Average daily shares traded | 2K | 5.1M | 6.2M | 3.2M | 3.7M |
Analyst Outlook
ARES leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: APO as "Buy", KKR as "Buy", CG as "Buy", ARES as "Buy". Consensus price targets imply 37.7% upside for KKR (target: $141) vs 18.1% for APO (target: $157). For income investors, ARES offers the higher dividend yield at 6.40% vs KKR's 0.78%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $157.25 | $141.14 | $64.14 | $171.13 |
| # AnalystsCovering analysts | — | 28 | 27 | 25 | 22 |
| Dividend YieldAnnual dividend ÷ price | — | +1.6% | +0.8% | +2.7% | +6.4% |
| Dividend StreakConsecutive years of raises | — | 3 | 6 | 0 | 7 |
| Dividend / ShareAnnual DPS | — | $2.14 | $0.80 | $1.36 | $8.08 |
| Buyback YieldShare repurchases ÷ mkt cap | +96.2% | +1.0% | +0.1% | +3.8% | 0.0% |
APO leads in 2 of 6 categories (Valuation Metrics, Total Returns). ARES leads in 1 (Analyst Outlook). 3 tied.
ALCY vs APO vs KKR vs CG vs ARES: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is ALCY or APO or KKR or CG or ARES a better buy right now?
For growth investors, Ares Management Corporation (ARES) is the stronger pick with 66.
6% revenue growth year-over-year, versus -11. 0% for KKR & Co. Inc. (KKR). Apollo Global Management, Inc. (APO) offers the better valuation at 18. 3x trailing P/E (14. 9x forward), making it the more compelling value choice. Analysts rate Apollo Global Management, Inc. (APO) a "Buy" — based on 28 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — ALCY or APO or KKR or CG or ARES?
On trailing P/E, Apollo Global Management, Inc.
(APO) is the cheapest at 18. 3x versus Ares Management Corporation at 64. 4x. On forward P/E, The Carlyle Group Inc. is actually cheaper at 12. 3x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Apollo Global Management, Inc. wins at 0. 20x versus Ares Management Corporation's 1. 19x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — ALCY or APO or KKR or CG or ARES?
Over the past 5 years, Ares Management Corporation (ARES) delivered a total return of +167.
8%, compared to +16. 6% for Alchemy Investments Acquisition Corp 1 (ALCY). Over 10 years, the gap is even starker: ARES returned +951. 4% versus ALCY's +16. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — ALCY or APO or KKR or CG or ARES?
By beta (market sensitivity over 5 years), Alchemy Investments Acquisition Corp 1 (ALCY) is the lower-risk stock at 0.
02β versus The Carlyle Group Inc. 's 1. 85β — meaning CG is approximately 7653% more volatile than ALCY relative to the S&P 500. On balance sheet safety, Alchemy Investments Acquisition Corp 1 (ALCY) carries a lower debt/equity ratio of 10% versus 197% for The Carlyle Group Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — ALCY or APO or KKR or CG or ARES?
By revenue growth (latest reported year), Ares Management Corporation (ARES) is pulling ahead at 66.
6% versus -11. 0% for KKR & Co. Inc. (KKR). On earnings-per-share growth, the picture is similar: Alchemy Investments Acquisition Corp 1 grew EPS 34. 4% year-over-year, compared to -28. 7% for KKR & Co. Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — ALCY or APO or KKR or CG or ARES?
The Carlyle Group Inc.
(CG) is the more profitable company, earning 16. 5% net margin versus 0. 0% for Alchemy Investments Acquisition Corp 1 — meaning it keeps 16. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: APO leads at 34. 4% versus 0. 0% for ALCY. At the gross margin level — before operating expenses — APO leads at 88. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is ALCY or APO or KKR or CG or ARES more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Apollo Global Management, Inc. (APO) is the more undervalued stock at a PEG of 0. 20x versus Ares Management Corporation's 1. 19x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, The Carlyle Group Inc. (CG) trades at 12. 3x forward P/E versus 20. 9x for Ares Management Corporation — 8. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for KKR: 37. 7% to $141. 14.
08Which pays a better dividend — ALCY or APO or KKR or CG or ARES?
In this comparison, ARES (6.
4% yield), CG (2. 7% yield), APO (1. 6% yield), KKR (0. 8% yield) pay a dividend. ALCY does not pay a meaningful dividend and should not be held primarily for income.
09Is ALCY or APO or KKR or CG or ARES better for a retirement portfolio?
For long-horizon retirement investors, Alchemy Investments Acquisition Corp 1 (ALCY) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
02)). The Carlyle Group Inc. (CG) carries a higher beta of 1. 85 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALCY: +16. 6%, CG: +291. 0%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between ALCY and APO and KKR and CG and ARES?
Both stocks operate in the Financial Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: ALCY is a small-cap quality compounder stock; APO is a mid-cap high-growth stock; KKR is a mid-cap quality compounder stock; CG is a mid-cap high-growth stock; ARES is a mid-cap high-growth stock. APO, KKR, CG, ARES pay a dividend while ALCY does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.